| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departments of Cell Biology [L. L., I. J. F.] and Medical Oncology [R. G. K., J. A.], The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030
The purpose of these studies was to determine whether nitric oxide produced by cytokine-activated murine lung vascular endothelial cells plays a role in their lytic destruction of M-5076 reticulum cell sarcoma. Vascular endothelial cells harvested from perfused lungs of mice were adapted to grow in culture. Cloned lines ascertained to be of endothelial origin were incubated in vitro with interferon
and tumor necrosis factor. Lysis of radiolabeled tumor cells and accumulation of nitrite in the culture medium were determined at several time points. The concentration of nitrite in the culture medium directly correlated with endothelial cell-mediated tumor cell lysis. Endothelial cells cultured in L-arginine-free medium did not produce significant tumor cell lysis nor accumulation of nitrite in the medium. Both tumor cell lysis and nitrite accumulation were observed when the deficient medium was reconstituted with L-arginine, suggesting that endothelial cell-mediated tumor lysis was dependent on L-arginine, a precursor of nitric oxide. Moreover, specific inhibition of nitric oxide synthesis by NG-methyl-L-arginine resulted in complete inhibition of endothelial cell-mediated lysis of the M-5076 reticulum cell sarcoma. Similarly, treatment of cytokine-activated endothelial cells with dexamethasone inhibited both target cell lysis and production of nitrite. Collectively, these results suggest that nitric oxide plays a major role in the lysis of tumor cells mediated by cytokine-activated endothelial cells.
1 Supported by NIH Grant R35-CA42107 from the National Cancer Institute, NIH.
2 To whom requests for reprints should be addressed, at the Department of Cell Biology, HMB 173, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030.
Received 11/30/90. Accepted 3/ 5/91.
This article has been cited by other articles:
![]() |
H. Yasuda, M. Yamaya, K. Nakayama, T. Sasaki, S. Ebihara, A. Kanda, M. Asada, D. Inoue, T. Suzuki, T. Okazaki, et al. Randomized Phase II Trial Comparing Nitroglycerin Plus Vinorelbine and Cisplatin With Vinorelbine and Cisplatin Alone in Previously Untreated Stage IIIB/IV Non-Small-Cell Lung Cancer J. Clin. Oncol., February 1, 2006; 24(4): 688 - 694. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gerloni, P. Castiglioni, and M. Zanetti The Cooperation between Two CD4 T Cells Induces Tumor Protective Immunity in MUC.1 Transgenic Mice J. Immunol., November 15, 2005; 175(10): 6551 - 6559. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Crowell, V. E. Steele, C. C. Sigman, and J. R. Fay Is Inducible Nitric Oxide Synthase a Target for Chemoprevention? Mol. Cancer Ther., August 1, 2003; 2(8): 815 - 823. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Qiu, F.W. Orr, D. Jensen, H. H. Wang, A. R. McIntosh, B. B. Hasinoff, D. M. Nance, S. Pylypas, K. Qi, C. Song, et al. Arrest of B16 Melanoma Cells in the Mouse Pulmonary Microcirculation Induces Endothelial Nitric Oxide Synthase-Dependent Nitric Oxide Release that Is Cytotoxic to the Tumor Cells Am. J. Pathol., February 1, 2003; 162(2): 403 - 412. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Medeiros, A. Morais, A. Vasconcelos, S. Costa, D. Pinto, J. Oliveira, P. Ferreira, and C. Lopes Outcome in Prostate Cancer: Association with Endothelial Nitric Oxide Synthase Glu-Asp298 Polymorphism at Exon 7 Clin. Cancer Res., November 1, 2002; 8(11): 3433 - 3437. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.-M. Simeone, S. Ekmekcioglu, L. D. Broemeling, E. A. Grimm, and A. M. Tari A Novel Mechanism by Which N-(4-hydroxyphenyl)retinamide Inhibits Breast Cancer Cell Growth: The Production of Nitric Oxide Mol. Cancer Ther., October 1, 2002; 1(12): 1009 - 1017. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Tendler, C. Bao, T. Wang, E. L. Huang, E. A. Ratovitski, D. A. Pardoll, and C. J. Lowenstein Intersection of Interferon and Hypoxia Signal Transduction Pathways in Nitric Oxide-induced Tumor Apoptosis Cancer Res., May 1, 2001; 61(9): 3682 - 3688. [Abstract] [Full Text] |
||||
![]() |
J. L. KIEL, J. E. PARKER, J. L. ALLS, J. KALNS, E. A. HOLWITT, L. J.V. STRIBLING, P. J. MORALES, and J. G. BRUNO Rapid Recovery and Identification of Anthrax Bacteria from the Environment Ann. N.Y. Acad. Sci., December 1, 2000; 916(1): 240 - 252. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. H. Wang, A. R. McIntosh, B. B. Hasinoff, E. S. Rector, N. Ahmed, D. M. Nance, and F. W. Orr B16 Melanoma Cell Arrest in the Mouse Liver Induces Nitric Oxide Release and Sinusoidal Cytotoxicity: A Natural Hepatic Defense against Metastasis Cancer Res., October 1, 2000; 60(20): 5862 - 5869. [Abstract] [Full Text] |
||||
![]() |
Q. Shi, Q. Xiong, B. Wang, X. Le, N. A. Khan, and K. Xie Influence of Nitric Oxide Synthase II Gene Disruption on Tumor Growth and Metastasis Cancer Res., May 1, 2000; 60(10): 2579 - 2583. [Abstract] [Full Text] |
||||
![]() |
C. Cahlin, J. Gelin, D. Delbro, C. Lönnroth, C. Doi, and K. Lundholm Effect of Cyclooxygenase and Nitric Oxide Synthase Inhibitors on Tumor Growth in Mouse Tumor Models with and without Cancer Cachexia Related to Prostanoids Cancer Res., March 1, 2000; 60(6): 1742 - 1749. [Abstract] [Full Text] |
||||
![]() |
K. Mortensen, J. Skouv, D. M. Hougaard, and L.-I. Larsson Endogenous Endothelial Cell Nitric-oxide Synthase Modulates Apoptosis in Cultured Breast Cancer Cells and Is Transcriptionally Regulated by p53 J. Biol. Chem., December 31, 1999; 274(53): 37679 - 37684. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Mortensen, S. Holck, I. J. Christensen, J. Skouv, D. M. Hougaard, J. Blom, and L.-I. Larsson Endothelial Cell Nitric Oxide Synthase in Peritumoral Microvessels Is a Favorable Prognostic Indicator in Premenopausal Breast Cancer Patients Clin. Cancer Res., May 1, 1999; 5(5): 1093 - 1097. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Hung, R. Hayashi, A. Lafond-Walker, C. Lowenstein, D. Pardoll, and H. Levitsky The Central Role of CD4+ T Cells in the Antitumor Immune Response J. Exp. Med., December 21, 1998; 188(12): 2357 - 2368. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Chlichlia, M. E. Peter, M. Rocha, C. Scaffidi, M. Bucur, P. H. Krammer, V. Schirrmacher, and V. Umansky Caspase Activation Is Required for Nitric Oxide-Mediated, CD95(APO-1/Fas)-Dependent and Independent Apoptosis in Human Neoplastic Lymphoid Cells Blood, June 1, 1998; 91(11): 4311 - 4320. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Finkel, C. Oddis, T. Jacob, S. Watkins, B. Hattler, and R. Simmons Negative inotropic effects of cytokines on the heart mediated by nitric oxide Science, July 17, 1992; 257(5068): 387 - 389. [Abstract] [PDF] |
||||
![]() |
J. Carretero, E. Obrador, J. M. Esteve, A. Ortega, J. A. Pellicer, F. V. Sempere, and J. M. Estrela Tumoricidal Activity of Endothelial Cells. INHIBITION OF ENDOTHELIAL NITRIC OXIDE PRODUCTION ABROGATES TUMOR CYTOTOXICITY INDUCED BY HEPATIC SINUSOIDAL ENDOTHELIUM IN RESPONSE TO B16 MELANOMA ADHESION IN VITRO J. Biol. Chem., July 6, 2001; 276(28): 25775 - 25782. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |